» Articles » PMID: 26055276

The Role of Dietary Cholesterol in Lipoprotein Metabolism and Related Metabolic Abnormalities: A Mini-review

Overview
Date 2015 Jun 10
PMID 26055276
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Cholesterol plays a vital role in cell biology. Dietary cholesterol or "exogenous" cholesterol accounts for approximately one-third of the pooled body cholesterol, and the remaining 70% is synthesized in the body (endogenous cholesterol). Increased dietary cholesterol intake may result in increased serum cholesterol in some individuals, while other subjects may not respond to dietary cholesterol. However, diet-increased serum cholesterol levels do not increase the low-density lipoprotein/high-density lipoprotein (LDL/HDL) cholesterol ratio, nor do they decrease the size of LDL particles or HDL cholesterol levels. Elevated levels of LDL cholesterol, reduced HDL cholesterol levels, and small, dense LDL particles are independent risk factors for coronary artery disease. Dietary cholesterol is the primary approach for treatment of conditions such as the Smith-Lemli-Opitz syndrome. Recent studies have highlighted mechanisms for absorption of dietary cholesterol. These studies have help understand how dietary and/or pharmaceutical agents inhibit cholesterol absorption and thereby reduce LDL cholesterol concentrations. In this article, various aspects of cholesterol metabolism, including dietary sources, absorption, and abnormalities in cholesterol metabolism, have been summarized and discussed.

Citing Articles

Adverse cardiac events of hypercholesterolemia are enhanced by sitagliptin in sprague dawley rats.

Palfrey H, Kumar A, Pathak R, Stone K, Gettys T, Murthy S Nutr Metab (Lond). 2024; 21(1):54.

PMID: 39080769 PMC: 11290187. DOI: 10.1186/s12986-024-00817-9.


Liver as a new target organ in Alzheimer's disease: insight from cholesterol metabolism and its role in amyloid-beta clearance.

Wu B, Liu Y, Li H, Zhu L, Zeng L, Zhang Z Neural Regen Res. 2024; 20(3):695-714.

PMID: 38886936 PMC: 11433892. DOI: 10.4103/1673-5374.391305.


MicroRNA-206 as a potential cholesterol-lowering drug is superior to statins in mice.

Li C, Tian J, Liu N, Song D, Steer C, Han Q J Lipid Res. 2024; 65(7):100576.

PMID: 38866328 PMC: 11292365. DOI: 10.1016/j.jlr.2024.100576.


Adverse Cardiac Events of Hypercholesterolemia Are Enhanced by Sitagliptin Administration in Sprague Dawley Rats.

Palfrey H, Kumar A, Pathak R, Stone K, Gettys T, Murthy S Res Sq. 2024; .

PMID: 38562676 PMC: 10984018. DOI: 10.21203/rs.3.rs-4075353/v1.


Serotonin Signaling through Lipid Membranes.

Kalinichenko L, Kornhuber J, Sinning S, Haase J, Muller C ACS Chem Neurosci. 2024; 15(7):1298-1320.

PMID: 38499042 PMC: 10995955. DOI: 10.1021/acschemneuro.3c00823.